Preoperative Short term endocrine therapy for hormonal receptor positive breast cancer
Phase 2
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000004726
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. During pregnancy or lactation 2. With active other cancer 3. History of drug allergy 4. Significant illness that might influence the tolerability of treatment (interstitual pneumonia or lung fibrosis, myocardial infarction or congestive heart failure at the past history, or patients who need treatment of ischemic heart disease, arryhythmia or vascular disorder) 5. Severe myelosuppression 6. Severe kidney failure or liver failure 7. Active infectious disease 8. Inflammatory or bilateral breast cancer 9. Patients whom doctors judged inadequate to the enrollment of this study by other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method